Using Scintigraphy to Study Extraintestinal MALT-Lymphoma
Author Information
Author(s): Raderer M, Traub T, Formanek M, Virgolini I, Österreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A
Primary Institution: University of Vienna
Hypothesis
Can somatostatin receptor scintigraphy effectively stage and monitor patients with extragastric MALT-type lymphoma?
Conclusion
Somatostatin receptor scintigraphy is an effective tool for staging and monitoring therapy in patients with extragastric MALT-type lymphomas.
Supporting Evidence
- All patients with primary extragastric lymphoma had positive scans at the site of histologically documented involvement before therapy.
- No positive scans were obtained in patients with dissemination following gastric lymphoma.
- In one patient, a positive scan indicated disease relapse in the lacrimal gland 9 months before clinical verification.
Takeaway
Doctors used a special scan to see how well patients with a certain type of lymphoma were doing, and it helped them find out if the disease was still there or if it had come back.
Methodology
Patients underwent SSTR-scintigraphy using 111In-DTPA-D-Phe1-Octreotide before and after therapy, with results compared to conventional staging.
Limitations
The study was limited to a small sample size and specific types of lymphoma.
Participant Demographics
30 patients, including 24 with primary extragastric MALT-type lymphoma and 5 with dissemination from gastric lymphoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website